The risk of AKI in patients treated with intravenous solutions containing hydroxyethyl starch.

Shaw AD, Kellum JA
Clin J Am Soc Nephrol. 2013 8 (3): 497-503

PMID: 23335037 · DOI:10.2215/CJN.10921012

MeSH Terms (9)

Acute Kidney Injury Evidence-Based Medicine Fluid Therapy Humans Hydroxyethyl Starch Derivatives Infusions, Intravenous Plasma Substitutes Risk Assessment Risk Factors

Connections (1)

This publication is referenced by other Labnodes entities: